Aethlon Medical (AEMD) Common Equity (2016 - 2024)
Aethlon Medical (AEMD) has disclosed Common Equity for 14 consecutive years, with $4.3 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Common Equity fell 43.06% year-over-year to $4.3 million, compared with a TTM value of $4.3 million through Dec 2024, down 43.06%, and an annual FY2024 reading of $5.8 million, down 61.72% over the prior year.
- Common Equity was $4.3 million for Q4 2024 at Aethlon Medical, down from $6.0 million in the prior quarter.
- Across five years, Common Equity topped out at $24.7 million in Q2 2021 and bottomed at $4.3 million in Q4 2024.
- Average Common Equity over 5 years is $13.3 million, with a median of $13.3 million recorded in 2020.
- The sharpest move saw Common Equity skyrocketed 65528.05% in 2020, then plummeted 61.72% in 2024.
- Year by year, Common Equity stood at $11.4 million in 2020, then surged by 79.81% to $20.6 million in 2021, then decreased by 15.95% to $17.3 million in 2022, then plummeted by 55.95% to $7.6 million in 2023, then plummeted by 43.06% to $4.3 million in 2024.
- Business Quant data shows Common Equity for AEMD at $4.3 million in Q4 2024, $6.0 million in Q3 2024, and $8.7 million in Q2 2024.